Toshiyuki Sasaguri
Overview
Explore the profile of Toshiyuki Sasaguri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yamamoto M, Takahashi-Yanaga F, Arioka M, Igawa K, Tomooka K, Yamaura K, et al.
J Hypertens
. 2020 Nov;
39(5):892-903.
PMID: 33252422
Background: We reported that 2,5-dimethylcelecoxib (DM-celecoxib), a celecoxib derivative that is unable to inhibit cyclooxygenase-2, prevented cardiac remodeling induced by sarcomeric gene mutation, left ventricular pressure overload, or β-adrenergic receptor...
12.
Eljamal K, Kajioka S, Maki T, Ushijima M, Kawagoe K, Lee K, et al.
Low Urin Tract Symptoms
. 2020 Oct;
13(2):299-307.
PMID: 33089671
Objective: To develop a new mouse model of underactive bladder (UAB) caused by chronic bladder outlet obstruction (BOO). Methods: BOO was created in 6-week-old male C57BL/6 mice using surgery to...
13.
Yoshihara T, Zaitsu M, Kubota S, Arima H, Sasaguri T
Sci Rep
. 2020 Feb;
10(1):2891.
PMID: 32076019
This study aimed to examine the effect of pool walking on renal function in pregnant women. Fifteen pregnant women (mean gestational age, 37.8 weeks) walked in a pool (depth 1.3 ...
14.
Fujita A, Hayamizu K, Yoshihara T, Zaitsu M, Shiraishi F, Arima H, et al.
JA Clin Rep
. 2020 Feb;
4(1):59.
PMID: 32025958
Introduction: To examine whether sex and polymorphisms of cytochrome P450 (CYP) 2B6 and UDP-glucuronosyltransferase (UGT) 1A9 affect the difference between predicted and measured plasma propofol concentration during continuous infusion by...
15.
Ohta Y, Kamide K, Hanada H, Morimoto S, Nakahashi T, Takiuchi S, et al.
Hypertens Res
. 2019 Nov;
43(3):220-226.
PMID: 31748705
We investigated changes in blood pressure (BP) and metabolic adverse effects, especially elevation of uric acid (UA), after treatment with a thiazide-like diuretic (TD) in patients with essential hypertension. Furthermore,...
16.
Tetsuo F, Arioka M, Miura K, Kai M, Kubo M, Igawa K, et al.
Cancer Sci
. 2019 Sep;
110(12):3761-3772.
PMID: 31553107
Differentiation-inducing factor-1 (DIF-1) has been reported to inhibit the proliferation of various mammalian cells by unknown means, although some possible mechanisms of its action have been proposed, including the activation...
17.
Morishige S, Takahashi-Yanaga F, Ishikane S, Arioka M, Igawa K, Kuroo A, et al.
Biochem Pharmacol
. 2019 Jun;
168:82-90.
PMID: 31229551
We previously reported that 2,5-dimethylcelecoxib (DM-celecoxib), a celecoxib derivative that is unable to inhibit cyclooxygenase-2, prevented cardiac remodeling by activating glycogen synthase kinase-3 (GSK-3) and prolonged the lifespan of heart...
18.
Yoshihara T, Zaitsu M, Shiraishi F, Arima H, Takahashi-Yanaga F, Arioka M, et al.
J Pharmacol Sci
. 2019 Feb;
139(3):209-214.
PMID: 30773300
The aim of this study was to investigate the contribution of gene polymorphisms, in combination with habitual caffeine consumption, to the effect of caffeine intake on hemodynamic and psychoactive parameters....
19.
Hayamizu K, Morimoto S, Nonaka M, Hoka S, Sasaguri T
Arch Biochem Biophys
. 2017 Nov;
637:40-47.
PMID: 29169900
The plant-derived flavonoid, quercetin (QCT), has many biological actions, including cardioprotective actions, resulting from its antioxidant and anti-inflammatory effects. In this study, effects of QCT and its metabolites on the...
20.
Arioka M, Takahashi-Yanaga F, Tatsumoto N, Sasaguri T
Biochem Biophys Res Commun
. 2017 Sep;
493(1):9-13.
PMID: 28939042
Chronic kidney disease (CKD) causes hyperphosphatemia and secondary hyperparathyroidism, leading to several disorders of bone metabolism. Although high concentrations of extracellular inorganic phosphate (Pi) inhibit osteoclastogenesis, the molecular mechanism of...